| Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Kenemans P, Foidart JM, Bundred NJ, Kubista E, von lancet oncology 10 (2), 135 - 146, 2009 | 436 | 2009 |
| Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging L Martincich, F Montemurro, G De Rosa, V Marra, R Ponzone, S Cirillo, ... Breast cancer research and treatment 83, 67-76, 2004 | 303 | 2004 |
| Angiopoietin‐2 expression in breast cancer correlates with lymph node invasion and short survival C Sfiligoi, A de Luca, I Cascone, V Sorbello, L Fuso, R Ponzone, N Biglia, ... International journal of cancer 103 (4), 466-474, 2003 | 265 | 2003 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 248 | 2021 |
| Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): a secondary analysis of the WAPM study on COVID-19 D Di Mascio, C Sen, G Saccone, A Galindo, A Grünebaum, J Yoshimatsu, ... Journal of perinatal medicine 48 (9), 950-958, 2020 | 206 | 2020 |
| Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight N Biglia, G Moggio, E Peano, P Sgandurra, R Ponzone, RE Nappi, ... The journal of sexual medicine 7 (5), 1891-1900, 2010 | 193 | 2010 |
| Objective and self‐reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study N Biglia, VE Bounous, A Malabaila, D Palmisano, DME Torta, M d'Alonzo, ... European journal of cancer care 21 (4), 485-492, 2012 | 174 | 2012 |
| Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study N Biglia, E Peano, P Sgandurra, G Moggio, E Panuccio, M Migliardi, ... Gynecological Endocrinology 26 (6), 404-412, 2010 | 171 | 2010 |
| miR148b is a major coordinator of breast cancer progression in a relapse‐associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1 D Cimino, C De Pitta, F Orso, M Zampini, S Casara, E Penna, E Quaglino, ... The FASEB Journal 27 (3), 1223-1235, 2013 | 159 | 2013 |
| Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases? N Biglia, A Cagnacci, M Gambacciani, S Lello, S Maffei, RE Nappi Climacteric 20 (4), 306-312, 2017 | 153 | 2017 |
| Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion MS Giretti, XD Fu, G De Rosa, I Sarotto, C Baldacci, S Garibaldi, ... PloS one 3 (5), e2238, 2008 | 147 | 2008 |
| Body mass index (BMI) and breast cancer: impact on tumor histopatologic features, cancer subtypes and recurrence rate in pre and postmenopausal women N Biglia, E Peano, P Sgandurra, G Moggio, S Pecchio, F Maggiorotto, ... Gynecological Endocrinology 29 (3), 263-267, 2013 | 146 | 2013 |
| Menopause after breast cancer: a survey on breast cancer survivors N Biglia, M Cozzarella, F Cacciari, R Ponzone, R Roagna, F Maggiorotto, ... Maturitas 45 (1), 29-38, 2003 | 146 | 2003 |
| Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study P Conte, A Frassoldati, G Bisagni, AA Brandes, M Donadio, O Garrone, ... Annals of Oncology 29 (12), 2328-2333, 2018 | 141 | 2018 |
| Identification of new genes associated with breast cancer progression by gene expression analysis of predefined sets of neoplastic tissues D Cimino, L Fuso, C Sfiligoi, N Biglia, R Ponzone, F Maggiorotto, G Russo, ... International journal of cancer 123 (6), 1327-1338, 2008 | 139 | 2008 |
| Lower body lymphedema in patients with gynecologic cancer N Biglia, V Zanfagnin, A Daniele, E Robba, VE Bounous Anticancer Research 37 (8), 4005-4015, 2017 | 137 | 2017 |
| Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels C Campagnoli, N Biglia, F Altare, MG Lanza, L Lesca, C Cantamessa, ... Gynecological Endocrinology 7 (4), 251-258, 1993 | 135 | 1993 |
| Human Kallikrein Gene 5 (KLK5) Expression by Quantitative PCR: An Independent Indicator of Poor Prognosis in Breast Cancer GM Yousef, A Scorilas, LG Kyriakopoulou, L Rendl, M Diamandis, ... Clinical chemistry 48 (8), 1241-1250, 2002 | 125 | 2002 |
| Vaginal oestrogen therapy after breast cancer: is it safe? R Ponzone, N Biglia, ME Jacomuzzi, F Maggiorotto, L Mariani, ... European Journal of Cancer 41 (17), 2673-2681, 2005 | 123 | 2005 |
| Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study G Bertelli, M Venturini, L Del Mastro, M Bergaglio, P Sismondi, N Biglia, ... Annals of Oncology 13 (6), 883-888, 2002 | 116 | 2002 |
Rossella E NappiProf of Obstetrics and Gynecology在 unipv.it 的电子邮件经过验证
Rossella E NappiProf of Obstetrics and Gynecology在 unipv.it 的电子邮件经过验证